Literature DB >> 2422542

Heteroclitic behaviour of some monoclonal antibodies against bovine growth hormone.

L A Retegui, A C Paladini.   

Abstract

Five monoclonal antibodies (MAbs) prepared against bovine growth hormone (bGH) were found to be directed against an immunodominant antigenic domain in bGH. MAbs D8 and H3 reacted equally well with bGH and ovine growth hormone and to a lesser extent with equine (eGH) or porcine (pGH) growth hormones while MAbs H1, H2 and C12 behaved as heteroclitic antibodies, i.e. they bound better a cross-reacting antigen (eGH on pGH) than the immunogen. The reactivity of bGH with the heteroclitic MAbs increased proportionally to the time that the native protein was kept frozen. Deamidation of bGH by treatment with alkali also increased its reactivity. Circular dichroism measurements indicated the occurrence of changes in the conformation of the bGH molecule by these treatments which presumably uncover normally buried or non-accesible epitopes. bGH shares epitopes with eGH and pGH which are immunologically expressed by bGH only when its native conformation is modified.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422542     DOI: 10.1016/0161-5890(86)90032-5

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Monoclonal antibodies against calcitonin. Characterization and application in light and electron microscopy immunocytochemistry.

Authors:  L Scopsi; J Arias; G Houen; G Racchetti; G L Fossati; Y M Galante
Journal:  Histochemistry       Date:  1988

2.  Stochastic humoral expression of human growth hormone epitopes.

Authors:  M Etcheverrigaray; A C Paladini; L A Retegui
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

3.  Monoclonal antibodies to human growth hormone induce an allosteric conformational change in the antigen.

Authors:  M M Mazza; L A Retegui
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

Review 4.  Overview on poly(ADP-ribose) immuno-biomedicine and future prospects.

Authors:  Yoshiyuki Kanai
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2016       Impact factor: 3.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.